Until Labs raises $58M to push boundaries of cryopreservation
Longevity Technology - 23-Sep-2025Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials
Danny Sullivan
Contributing editor to Longevity Technology
Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Details last updated 10-Feb-2020
Articles written by Danny Sullivan
Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform
Longevity Technology - 19-Sep-2025First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
Revalia Bio raises $14.5M to advance human organ-based drug testing
Longevity Technology - 09-Sep-2025Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients
NRG raises $67M for mitochondrial drugs in neurodegeneration
Longevity Technology - 08-Sep-2025Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy
Longevity Technology - 02-Sep-2025Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
Minovia powers up mitochondrial medicine
Longevity Technology - 01-Sep-2025$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Debut raises $20M to pioneer AI-driven skin longevity ingredients
Longevity Technology - 28-Aug-2025Startup uses AI to explore billions of molecules for next-gen skincare innovation
OneSkin raises $20M to boost skin longevity science
Longevity Technology - 08-Aug-2025New funding will help expand OneSkin’s reach and target ageing at the cellular level
Sava raises $19m for next-gen glucose monitoring wearable
Longevity Technology - 31-Jul-2025With $19 million funding, the startup plans regulatory approvals and scaling
Immortal Dragons has launched with $40 million to support longevity research
Longevity Technology - 18-Jul-2025The fund bridges East-West collaboration and acts quickly using its own capital
Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies
Longevity Technology - 15-Jul-2025New investment fuels development of therapies targeting mtDNA-related energy disorders
Epigenica debuts scalable tech to track epigenetic ageing
Longevity Technology - 04-Jul-2025Epigenica launches scalable tech to decode epigenetic ageing and disease markers
Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Parallel Bio raises $21m to replace animal testing with human immune organoids
Longevity Technology - 17-Jun-2025New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-May-2025Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025The company is still in early stages but attracting strong investor interest
Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Display all articles
